Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Shares Outstanding (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Shares Outstanding for 15 consecutive years, with $79.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 3.08% to $79.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $79.7 million through Dec 2025, up 3.08% year-over-year, with the annual reading at $79.7 million for FY2025, 3.08% up from the prior year.
  • Shares Outstanding for Q4 2025 was $79.7 million at Niagen Bioscience, roughly flat from $79.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $79.7 million in Q4 2025, with the low at $67.7 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $73.6 million, with a median of $74.9 million recorded in 2023.
  • The sharpest move saw Shares Outstanding increased 13.58% in 2021, then rose 0.11% in 2022.
  • Over 5 years, Shares Outstanding stood at $68.1 million in 2021, then increased by 9.45% to $74.6 million in 2022, then grew by 0.56% to $75.0 million in 2023, then rose by 3.13% to $77.3 million in 2024, then rose by 3.08% to $79.7 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $79.7 million, $79.6 million, and $79.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.